Renren Bai

机构：Hangzhou Normal University, State Administration of Traditional Chinese Medicine of the People's Republic of China · ORCID：0000-0002-3511-5794

发表论文 111 篇 · 总被引 3734 次 · h-index 31

代表论文

• Discovery of plant-derived anti-tumor natural products: Potential leads for anti-tumor drug discovery (2023 · Bioorganic Chemistry · 被引 87)
• CXCR4/CXCL12 axis: “old” pathway as “novel” target for anti‐inflammatory drug discovery (2024 · Medicinal Research Reviews · 被引 43)
• Click chemistry-aided drug discovery: A retrospective and prospective outlook (2023 · European Journal of Medicinal Chemistry · 被引 43)
• Deep learning for advancing peptide drug development: Tools and methods in structure prediction and design (2024 · European Journal of Medicinal Chemistry · 被引 41)
• Discovery of matrix metalloproteinase inhibitors as anti-skin photoaging agents (2024 · European Journal of Medicinal Chemistry · 被引 35)
• Small-Molecule Tyrosinase Inhibitors for Treatment of Hyperpigmentation (2025 · Molecules · 被引 28)